We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
-0.03%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
AUM
$632M
AUM Growth
+$15.6M
Cap. Flow
+$22.2M
Cap. Flow %
3.51%
Top 10 Hldgs %
35.59%
Holding
1,357
New
91
Increased
542
Reduced
171
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 8.77%
2 Financials 4.36%
3 Consumer Discretionary 2.73%
4 Healthcare 2.56%
5 Consumer Staples 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
1176
Unity
U
$18.9B
$629 ﹤0.01%
28
R icon
1177
Ryder
R
$10.1B
$627 ﹤0.01%
4
UGI icon
1178
UGI
UGI
$7.33B
$621 ﹤0.01%
22
GTLB icon
1179
GitLab
GTLB
$6.58B
$620 ﹤0.01%
11
FLYW icon
1180
Flywire
FLYW
$2.16B
$619 ﹤0.01%
30
QQQJ icon
1181
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
$618 ﹤0.01%
+20
New +$621
AVAV icon
1182
AeroVironment
AVAV
$9.45B
$616 ﹤0.01%
4
BRO icon
1183
Brown & Brown
BRO
$23.9B
$612 ﹤0.01%
6
DNLI icon
1184
Denali Therapeutics
DNLI
$3.97B
$611 ﹤0.01%
30
SKX
1185
DELISTED
Skechers
SKX
$605 ﹤0.01%
9
KTB icon
1186
Kontoor Brands
KTB
$4.26B
$598 ﹤0.01%
7
MYRG icon
1187
MYR Group
MYRG
$5.25B
$595 ﹤0.01%
+4
New +$559
HLNE icon
1188
Hamilton Lane
HLNE
$5.57B
$592 ﹤0.01%
4
RNAM
1189
DELISTED
Avidity Biosciences
RNAM
$582 ﹤0.01%
20
MOD icon
1190
Modine Manufacturing
MOD
$10.4B
$580 ﹤0.01%
5
NVST icon
1191
Envista
NVST
$4.52B
$579 ﹤0.01%
30
RGEN icon
1192
Repligen
RGEN
$9.25B
$576 ﹤0.01%
4
ASO icon
1193
Academy Sports + Outdoors
ASO
$2.98B
$575 ﹤0.01%
+10
New +$527
CLDI icon
1194
Calidi Biotherapeutics
CLDI
$3.96M
$575 ﹤0.01%
3
RXO icon
1195
RXO
RXO
$3.58B
$572 ﹤0.01%
24
SPE
1196
Special Opportunities Fund
SPE
$144M
$571 ﹤0.01%
41
SYM icon
1197
Symbotic
SYM
$5.22B
$569 ﹤0.01%
24
HRI icon
1198
Herc Holdings
HRI
$5.61B
$568 ﹤0.01%
3
COMP icon
1199
Compass
COMP
$9.66B
$567 ﹤0.01%
97
EDR
1200
DELISTED
Endeavor Group Holdings, Inc.
EDR
$563 ﹤0.01%
18

Similar funds

CVA Family Office's Q4 2024 Portfolio in Review

As of Q4 2024, CVA Family Office held 1,357 positions worth $632M, up 2.5% from $616M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CVA Family Office deployed $22.2M of net new capital in Q4 2024, opening 91 new positions and adding to 542 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 9,892 shares worth $749K.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, up from 8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $3.99M trimmed.

  • CVA Family Office's largest Q4 2024 buy was JPMorgan US Tech Leaders ETF: 9,892 shares worth $749K.
  • CVA Family Office added most to Invesco QQQ Trust in Q4 2024, an estimated $2.84M increase.
  • CVA Family Office's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $3.99M.
  • CVA Family Office fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $101K.
  • CVA Family Office's ten largest holdings make up 36% of its $632M portfolio in Q4 2024.
  • CVA Family Office opened 91 new positions and closed 70 in Q4 2024.
  • CVA Family Office's portfolio value rose 2.5% quarter-over-quarter to $632M.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.